Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis
Elevated anti-PTX3 antibodies in RA indicate residual active disease despite controlled inflammation. They may serve as a biomarker for true active disease, especially in seronegative RA patients who might be undertreated.
Authors
- Francesca Frizzera (ORCID: https://orcid.org/0000-0002-0611-5605)
- Mariangela Salvato (ORCID: https://orcid.org/0009-0005-5809-6716)
- Alessandro Giollo (ORCID: https://orcid.org/0000-0001-9355-7673)
- Andrea Doria (ORCID: https://orcid.org/0000-0003-0548-4983)
- Anna Ghirardello
- Margherita Zen (ORCID: https://orcid.org/0000-0003-0835-1406)
- Antonia Calligaro
- Costantino Botsios
Institutions
- University of Padua (IT)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1093/rheumatology/keae529
- Citations
- 5
- Primary Topic
- Biomarkers in Disease Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.20